切换至 "中华医学电子期刊资源库"

中华肾病研究电子杂志 ›› 2020, Vol. 09 ›› Issue (02) : 86 -89. doi: 10.3877/cma.j.issn.2095-3216.2020.02.008

所属专题: 文献

综述

肾淀粉样变性病的病理诊断与分型、分级的研究进展
陈思羽1, 韩伟霞1, 王晨1,()   
  1. 1. 030001 山西太原,山西医科大学第二医院病理科
  • 收稿日期:2020-01-10 出版日期:2020-04-28
  • 通信作者: 王晨

Research progress in pathological diagnosis, typing and grading of renal amyloidosis

Siyu Chen1, Weixia Han1, Chen Wang1,()   

  1. 1. Department of Pathology, Second Hospital of Shanxi Medical University, Taiyuan 030001, Shanxi Province, China
  • Received:2020-01-10 Published:2020-04-28
  • Corresponding author: Chen Wang
  • About author:
    Corresponding author: Wang Chen, Email:
引用本文:

陈思羽, 韩伟霞, 王晨. 肾淀粉样变性病的病理诊断与分型、分级的研究进展[J/OL]. 中华肾病研究电子杂志, 2020, 09(02): 86-89.

Siyu Chen, Weixia Han, Chen Wang. Research progress in pathological diagnosis, typing and grading of renal amyloidosis[J/OL]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2020, 09(02): 86-89.

淀粉样变性病是由蛋白异常折叠后形成不溶性β-片层构型的淀粉样物发生异常沉积的一类代谢病,肾脏是最常受累的器官之一,诊断主要依赖肾穿刺病理活检。肾淀粉样变性病的临床及病理表现多样,病因学诊断及分型困难,无统一的病理学分级系统,临床缺乏有效的干预治疗。本文将对肾淀粉样变性病的病理表现、诊断及分型分级予以综述,以期为该疾病的诊断、治疗及预后评估提供依据。

Amyloidosis is a disorder caused by extracellular deposition of misfolded proteins in an insoluble beta-pleated physical format. The kidney is a frequent site of amyloid deposition. Diagnosis of renal amyloidosis is based on the renal pathology biopsy. As the clinical features and pathological manifestations of renal amyloidosis are diverse, the diagnosis and typing of renal amyloidosis can sometimes be problematic. There is not a unified pathological grading system and lacks effective clinical interventions for renal amyloidosis. In this manuscript, we described the pathological manifestations, diagnosis, typing, and grading of renal amyloidosis, so as to provide a basis for the diagnosis, treatment, and prognosis evaluation of the disease.

图1 肾淀粉样变性病分型流程图
表1 各型肾淀粉样变性病的临床病理特点
表2 肾淀粉样变性病的病理评分标准
[1]
Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade [J]. Ann Rev Biochem, 2017, 86: 27-68.
[2]
何娅妮,张炜炜. 肾病综合征的流行病学现状 [J]. 中华肾病研究电子杂志,2017, 6(4): 149-153.
[3]
Benson MD, Buxbaum JN, Eisenberg DS, et al. Amyloid nomenclature 2018: recommendations by the International Society of Amyloidosis (ISA) nomenclature committee [J]. Amyloid, 2019, 25(4): 1-5.
[4]
Solanki R, Solanki MK, Hemrajani D, et al. A study of detection and comparison of immunofluorescence on formalin-fixed paraffin-embedded tissue with fresh frozen renal biopsy specimen [J]. Saudi J Kidney Dis Transpl, 2019, 30(2): 350-358.
[5]
Aoki M, Kang D, Katayama A, et al. Optimal conditions and the advantages of using laser microdissection and liquid chromatography tandem mass spectrometry for diagnosing renal amyloidosis [J]. Clin Exp Nephrol, 2018, 22(4): 871-880.
[6]
Cottini F, Bott C, Nadasdy T, et al. A novel APOA1 mutation in a patient with renal amyloidosis: unveiling amyloid by next-generation sequencing [J]. Amyloid, 2019, 26(5): 1-2.
[7]
Masahide Y, Tsuneaki Y, Yoshiki S, et al. Hereditary fibrinogen A α-chain amyloidosis in Asia: clinical and molecular characteristics [J]. Int J Mol Sci, 2018, 19(1): 320.
[8]
Said SM, Sethi S, Valeri AM, et al. Renal amyloidosis: origin and clinicopathologic correlations of 474 recent cases [J]. Clin J Am Soc Nephrol, 2013, 8(9): 1515-1523.
[9]
Sen S, Sarsik B. A proposed histopathologic classification, scoring, and grading system for renal amyloidosis standardization of renal amyloid biopsy report [J]. Arch Pathol Lab Med, 2010, 134(4): 532-544.
[10]
Rezk T, Gilbertson JA, Rowczenio D, et al. Diagnosis, pathogenesis and outcome in leucocyte chemotactic factor 2 (ALECT2) amyloidosis [J]. Nephrol Dial Transplant, 2018, 33(2): 241-247.
[11]
Sethi S, Theis JD. Pathology and diagnosis of renal non-AL amyloidosis [J]. J Nephrol, 2017, 31(3): 343-350.
[12]
Yao Y, Wang SX, ZhangYK, et al. A clinicopathological analysis in a large cohort of Chinese patients with renal amyloid light-chain amyloidosis [J]. Nephrol Dial Transplant, 2013, 28(3): 689-697.
[13]
Castano E, Palmer MB, Vigneault C. Comparison of amyloid deposition in human kidney biopsies as predictor of poor patient outcome [J]. BMC Nephrol, 2015, 16: 64.
[14]
林峥,林春,江辉,等. 195例淀粉样变性肾病临床病理学相关因素分析 [J]. 湖北医药学院学报,2016, 35(6): 561-565.
[1] 杜华, 徐晓艳, 孙微, 海玲, 刘霞, 曹颖, 苏畅, 师迎旭. 乳腺癌研究中常用细胞系的特征及选择[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(02): 119-123.
[2] 张升荣, 李晓东, 王伟. B族链球菌感染分型对孕产妇未足月胎膜早破的预测价值及其与绒毛膜羊膜炎的关系[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 170-175.
[3] 王欢欢, 郑少祥, 郝金锦, 陈文亮. 胃癌分子分型的研究进展及相关联系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(03): 229-234.
[4] 赵燕, 王昱昊, 王娟, 杨建军. 胃肠间质瘤的诊疗进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(01): 66-70.
[5] 赵国栋, 陆锦俊, 许永强. 不同肠系膜下动脉分型的腹腔镜低位直肠前切除术临床效果及经验总结[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(03): 334-337.
[6] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[7] 杨莎莎, 张毛为, 孙宜田, 刘亚南, 位娟, 魏建, 陈碧. 结缔组织疾病相关间质性肺病并发小气道功能障碍临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 738-743.
[8] 蒋永东, 耿启砥, 吴宇峰, 高世华. 肩锁关节脱位的文献计量学分析[J/OL]. 中华肩肘外科电子杂志, 2024, 12(03): 246-256.
[9] 王素霞. IgA肾病的病理诊断与鉴别诊断[J/OL]. 中华肾病研究电子杂志, 2024, 13(02): 120-120.
[10] 张峻, 赵建民, 姚晓克, 吉浩宇, 越瑞祥. 增加CT对桡骨远端骨折分型的可靠性及可重复性评价[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 264-272.
[11] 周锐, 罗飞. 骨质疏松椎体骨折的分型进展[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(05): 315-320.
[12] 李金星, 陈志宏, 孙铭均, 孙岩岩, 党树伟, 李广恩, 彭书奇, 付大伟, 李宏伟, 李国东. 基于多层螺旋CT 的腹腔干解剖变异与新分型研究[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 756-763.
[13] 潘文志, 李伟, 周达新, 潘翠珍, 魏来, 葛均波. 二尖瓣反流的新分型及相应经导管缘对缘修复手术策略[J/OL]. 中华心脏与心律电子杂志, 2024, 12(01): 10-13.
[14] 陆远欣, 龚莉琳, 曾梦华. 肥胖与非酒精性脂肪肝研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(02): 113-119.
[15] 金安松, 邹玉松, 刘玖涛, 薛凤麟, 庞爱兰. 孤立性颅内浆细胞瘤一例及相关文献复习[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 495-500.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?